The epidemiology of sepsis in the United States from 1979 through 2000.

BACKGROUND Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.

[1]  M. Langer,et al.  The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock , 1995, Intensive Care Medicine.

[2]  D. Pittet,et al.  Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients , 1995, Intensive Care Medicine.

[3]  Susan L Ettner,et al.  Contribution of major diseases to disparities in mortality. , 2002, The New England journal of medicine.

[4]  A. M. Fendrick,et al.  Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  G. Martin,et al.  The ICD-9 code for septicemia maintains a high positive predictive value for clinical sepsis , 2002 .

[6]  J. le Gall,et al.  Erratum to: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.

[7]  Corinne Alberti,et al.  Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.

[8]  S. Opal,et al.  High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .

[9]  K D Kochanek,et al.  Deaths: final data for 1999. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[10]  R. Wenzel,et al.  Severe sepsis-national estimates. , 2001, Critical care medicine.

[11]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[12]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[13]  G. Rothe,et al.  Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis , 2001, Critical care medicine.

[14]  R. Wenzel,et al.  The impact of hospital-acquired bloodstream infections. , 2001, Emerging infectious diseases.

[15]  R. Wenzel,et al.  Managing antibiotic resistance. , 2000, The New England journal of medicine.

[16]  D. Heyland,et al.  Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life , 2000, Critical care medicine.

[17]  J. A. Kruse,et al.  E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. , 2000, JAMA.

[18]  Charles J. Fisher,et al.  Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation , 2000, Critical care medicine.

[19]  C. Brun-Buisson,et al.  The epidemiology of the systemic inflammatory response , 2000, Intensive Care Medicine.

[20]  J. Dhainaut,et al.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.

[21]  A. Hoeft,et al.  Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. , 1999, Critical care medicine.

[22]  D C Angus,et al.  Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. , 1999, American journal of respiratory and critical care medicine.

[23]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[24]  A P Wheeler,et al.  Treating patients with severe sepsis. , 1999, The New England journal of medicine.

[25]  G. Bernard,et al.  Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research , 1999 .

[26]  J. Vincent,et al.  Has the mortality of septic shock changed with time. , 1998, Critical care medicine.

[27]  T. Evans,et al.  Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.

[28]  L. Iezzoni Assessing Quality Using Administrative Data , 1997, Annals of Internal Medicine.

[29]  D. Bates,et al.  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.

[30]  J. Vincent,et al.  Dear SIRS, I'm sorry to say that I don't like you... , 1997, Critical care medicine.

[31]  R. Wenzel,et al.  Long-Term Survival and Function After Suspected Gram-Negative Sepsis , 1996 .

[32]  F. Stüber,et al.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.

[33]  K. Steinberg,et al.  Improved Survival of Patients with Acute Respiratory Distress Syndrome (ARDS): 1983???1993 , 1995 .

[34]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[35]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[36]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[37]  J. Verhoef,et al.  The sepsis syndrome in a Dutch university hospital. Clinical observations. , 1993, Archives of internal medicine.

[38]  Z. Yuan,et al.  Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States. , 1993, JAMA.

[39]  J. Whittle,et al.  Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. , 1993, The New England journal of medicine.

[40]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[41]  A. Fein,et al.  Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. , 1993, JAMA.

[42]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[43]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[44]  F. Ognibene,et al.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.

[45]  Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. , 1990, MMWR. Morbidity and mortality weekly report.

[46]  Hsia Dc,et al.  Accuracy of Diagnostic Coding for Medicare Patients under the Prospective-Payment System , 1988 .